Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Cellect Biotechnology Ltd.

NASDAQ: APOPHealthcare / Biotechnology / Israel
1.13+0.0600+5.61%Vol 224 9081Y Perf -85.20%
Feb 20th, 2019 16:00
BID1.10 ASK1.12
Open1.10 Previous Close1.07
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.00 
Analyst Rating
— 0.00
Potencial %
961.95 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)6 
Earnings Rating
Neutral
Price Range Ratio 52wk %
1.90 
Earnings Date
18th Mar 2019

Today's Price Range

1.061.13

 

52wk Range

1.007.85

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Neutral
Performance
1 Month
-60.35%
3 Months
-70.42%
6 Months
-76.60%
1 Year
-85.20%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
APOP1.130.06005.61
AAPL172.031.10000.64
GOOG1 113.80-4.7600-0.43
MSFT107.15-1.0200-0.94
XOM78.530.30000.38
WFC49.810.43000.87
JNJ136.350.66000.49
FB162.560.27000.17
GE10.10-0.0300-0.30
JPM105.690.51000.48
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
7.00
Current Ratio
7.00
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-1 667.30
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.57
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.40
Cash Flow Per Share
-0.94
Price to Tangible Book
1.57
Book Value per Share
0.69
Enterprise Value (in ths.)
-4 481
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-105.20
Return on Assets (5Y Avg)
-
ROA last 12 Months
-63.83
Return on Capital (5Y Avg)
-
ROC last 12 Months
-105.98
Return on invested Capital Q
-35.31
Return on invested Capital Y
-103.23
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.28-0.29-3.57
Q02 2018-0.29-0.2610.34
Q01 2018-0.30-0.1646.67
Q04 2017-0.31-0.1648.39
Q03 2017-0.30-0.39-30.00
Q02 2017-0.22-0.23-4.55
Q01 2017-0.22-0.0481.82
Q04 2016-0.20-0.0195.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.36-24.14Negative
12/2018 FY-1.07-9.18Negative
3/2019 QR-0.33-6.45Negative
12/2019 FY-1.228.27Positive
Next Report Date18th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume224 908
Shares Outstanding (in ths.)5 440
Trades Count540
Dollar Volume236 561
Avg. Volume201 554
Avg. Weekly Volume317 590
Avg. Monthly Volume339 183
Avg. Quarterly Volume123 558

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

59%41%

Bearish Bullish

48%52%

Bearish Bullish

54%46%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0
0 (0.00 %)
0 (0.00 %)
Hold
0
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0
0 (0.00 %)
0 (0.00 %)
Strong Sell
0
0 (0.00 %)
0 (0.00 %)
Rating-Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News